image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 0.9269
-2.43 %
$ 15.7 M
Market Cap
-1.19
P/E
1. INTRINSIC VALUE

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.[ Read More ]

The intrinsic value of one MBOT stock under the base case scenario is HIDDEN Compared to the current market price of 0.927 USD, Microbot Medical Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart MBOT

image
FINANCIALS
0 REVENUE
0.00%
-9.86 M OPERATING INCOME
25.80%
-10.7 M NET INCOME
18.44%
-8.53 M OPERATING CASH FLOW
26.11%
1.97 M INVESTING CASH FLOW
151.43%
6.56 M FINANCING CASH FLOW
51.67%
0 REVENUE
0.00%
0 OPERATING INCOME
100.00%
-3.22 M NET INCOME
-30.43%
-2.76 M OPERATING CASH FLOW
-40.98%
140 K INVESTING CASH FLOW
-88.20%
633 K FINANCING CASH FLOW
-69.48%
Balance Sheet Decomposition Microbot Medical Inc.
image
Current Assets 7.92 M
Cash & Short-Term Investments 6.38 M
Receivables 0
Other Current Assets 1.54 M
Non-Current Assets 406 K
Long-Term Investments 0
PP&E 406 K
Other Non-Current Assets 0
Current Liabilities 3.79 M
Accounts Payable 357 K
Short-Term Debt 191 K
Other Current Liabilities 3.24 M
Non-Current Liabilities 40 K
Long-Term Debt 40 K
Other Non-Current Liabilities 0
EFFICIENCY
Earnings Waterfall Microbot Medical Inc.
image
Revenue 0
Cost Of Revenue 106 K
Gross Profit -106 K
Operating Expenses 9.86 M
Operating Income -9.86 M
Other Expenses 885 K
Net Income -10.7 M
RATIOS
0.00% GROSS MARGIN
0.00%
0.00% OPERATING MARGIN
0.00%
0.00% NET MARGIN
0.00%
-238.61% ROE
-238.61%
-128.98% ROA
-128.98%
-218.95% ROIC
-218.95%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Microbot Medical Inc.
image
Net Income -10.7 M
Depreciation & Amortization 106 K
Capital Expenditures -33 K
Stock-Based Compensation 1.39 M
Change in Working Capital -11 K
Others 707 K
Free Cash Flow -8.57 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Microbot Medical Inc.
image
MBOT has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Microbot Medical Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
4 years ago
Oct 12, 2020
Sell 157 K USD
Bornstein Yoseph
Director
- 20000
7.8449 USD
4 years ago
Oct 19, 2020
Sell 38.7 K USD
Bornstein Yoseph
Director
- 4881
7.9358 USD
4 years ago
Oct 05, 2020
Sell 157 K USD
Bornstein Yoseph
Director
- 20000
7.8449 USD
4 years ago
Oct 05, 2020
Sell 115 K USD
Bornstein Yoseph
Director
- 14881
7.7423 USD
4 years ago
Oct 05, 2020
Sell 39.6 K USD
Bornstein Yoseph
Director
- 5119
7.7431 USD
4 years ago
Aug 17, 2020
Sell 153 K USD
Bornstein Yoseph
Director
- 15000
10.1784 USD
4 years ago
Aug 17, 2020
Sell 1.42 K USD
Bornstein Yoseph
Director
- 119
11.9113 USD
4 years ago
Dec 23, 2019
Sell 400 K USD
Gadot Harel
Chairman, President and CEO
- 40000
10 USD
6 years ago
Jan 09, 2018
Sell 37.2 K USD
Bornstein Yoseph
director, 10 percent owner:
- 35000
1.0626 USD
6 years ago
Jan 03, 2018
Sell 2.88 K USD
Bornstein Yoseph
director, 10 percent owner:
- 2868
1.0056 USD
6 years ago
Jan 02, 2018
Sell 42.5 K USD
Bornstein Yoseph
director, 10 percent owner:
- 42132
1.0091 USD
6 years ago
Dec 27, 2017
Sell 14.6 K USD
Bornstein Yoseph
director, 10 percent owner:
- 14257
1.0222 USD
6 years ago
Dec 26, 2017
Sell 31.4 K USD
Bornstein Yoseph
director, 10 percent owner:
- 30743
1.0219 USD
6 years ago
Dec 19, 2017
Sell 33 K USD
Bornstein Yoseph
director, 10 percent owner:
- 32067
1.03 USD
6 years ago
Dec 20, 2017
Sell 13.3 K USD
Bornstein Yoseph
director, 10 percent owner:
- 12933
1.0306 USD
6 years ago
Dec 13, 2017
Sell 858 USD
Bornstein Yoseph
director, 10 percent owner:
- 841
1.02 USD
6 years ago
Dec 12, 2017
Sell 45.8 K USD
Bornstein Yoseph
director, 10 percent owner:
- 44159
1.0372 USD
6 years ago
Dec 06, 2017
Sell 16.2 K USD
Bornstein Yoseph
director, 10 percent owner:
- 15375
1.0509 USD
6 years ago
Dec 05, 2017
Sell 32.1 K USD
Bornstein Yoseph
director, 10 percent owner:
- 29625
1.0845 USD
6 years ago
Dec 04, 2017
Bought 11 K USD
Waizer Yoav Zvi
Director
+ 10000
1.1 USD
6 years ago
Dec 05, 2017
Sell 10.8 K USD
Waizer Yoav Zvi
Director
- 10000
1.08 USD
6 years ago
Nov 28, 2017
Sell 48.3 K USD
Bornstein Yoseph
director, 10 percent owner:
- 45000
1.0733 USD
6 years ago
Nov 21, 2017
Sell 54.5 K USD
Bornstein Yoseph
director, 10 percent owner:
- 45000
1.2104 USD
7 years ago
Oct 24, 2017
Sell 28.5 K USD
Bornstein Yoseph
director, 10 percent owner:
- 25000
1.1382 USD
7 years ago
Oct 24, 2017
Sell 28.3 K USD
Bornstein Yoseph
director, 10 percent owner:
- 25000
1.1318 USD
7 years ago
Oct 17, 2017
Sell 29.2 K USD
Bornstein Yoseph
director, 10 percent owner:
- 25000
1.1687 USD
7 years ago
Oct 17, 2017
Sell 28.9 K USD
Bornstein Yoseph
director, 10 percent owner:
- 25000
1.1567 USD
7 years ago
Oct 10, 2017
Sell 34.2 K USD
Bornstein Yoseph
director, 10 percent owner:
- 25000
1.3671 USD
7 years ago
Oct 10, 2017
Sell 34.7 K USD
Bornstein Yoseph
director, 10 percent owner:
- 25000
1.3891 USD
7 years ago
Oct 05, 2017
Sell 25.7 K USD
Shoham Moshe
Director
- 17100
1.5017 USD
7 years ago
Oct 09, 2017
Sell 24.9 K USD
Shoham Moshe
Director
- 16600
1.5 USD
7 years ago
Oct 05, 2017
Sell 32.8 K USD
Bornstein Yoseph
director, 10 percent owner:
- 22000
1.4908 USD
7 years ago
Oct 03, 2017
Sell 29.7 K USD
Bornstein Yoseph
director, 10 percent owner:
- 25000
1.1883 USD
7 years ago
Oct 03, 2017
Sell 29.3 K USD
Bornstein Yoseph
director, 10 percent owner:
- 25000
1.1735 USD
7 years ago
Oct 04, 2017
Sell 4.44 K USD
Bornstein Yoseph
director, 10 percent owner:
- 3000
1.48 USD
7 years ago
Sep 26, 2017
Sell 31.2 K USD
Bornstein Yoseph
director, 10 percent owner:
- 25000
1.2487 USD
7 years ago
Sep 26, 2017
Sell 30.7 K USD
Bornstein Yoseph
director, 10 percent owner:
- 25000
1.2273 USD
7 years ago
Sep 15, 2017
Sell 93.7 K USD
Shoham Moshe
Director
- 74975
1.25 USD
7 years ago
Sep 15, 2017
Sell 36 K USD
Shoham Moshe
Director
- 28657
1.255 USD
7 years ago
Sep 15, 2017
Sell 51 K USD
Shoham Moshe
Director
- 40500
1.26 USD
7 years ago
Sep 15, 2017
Sell 25.6 K USD
Shoham Moshe
Director
- 20276
1.265 USD
7 years ago
Sep 15, 2017
Sell 507 USD
Shoham Moshe
Director
- 400
1.2675 USD
7 years ago
Sep 15, 2017
Sell 34.8 K USD
Shoham Moshe
Director
- 27384
1.27 USD
7 years ago
Sep 15, 2017
Sell 1.53 K USD
Shoham Moshe
Director
- 1200
1.275 USD
7 years ago
Sep 15, 2017
Sell 18.4 K USD
Shoham Moshe
Director
- 14400
1.28 USD
7 years ago
Sep 15, 2017
Sell 14.2 K USD
Shoham Moshe
Director
- 11083
1.285 USD
7 years ago
Sep 15, 2017
Sell 8.34 K USD
Shoham Moshe
Director
- 6463
1.29 USD
7 years ago
Sep 15, 2017
Sell 11.7 K USD
Shoham Moshe
Director
- 9001
1.295 USD
7 years ago
Sep 15, 2017
Sell 8.45 K USD
Shoham Moshe
Director
- 6500
1.3 USD
7 years ago
Sep 15, 2017
Sell 1.92 K USD
Shoham Moshe
Director
- 1471
1.305 USD
7 years ago
Sep 15, 2017
Sell 9.81 K USD
Shoham Moshe
Director
- 7490
1.31 USD
7 years ago
Sep 15, 2017
Sell 264 USD
Shoham Moshe
Director
- 200
1.32 USD
7 years ago
Sep 19, 2017
Sell 29.9 K USD
Bornstein Yoseph
director, 10 percent owner:
- 25000
1.1941 USD
7 years ago
Sep 19, 2017
Sell 29.4 K USD
Bornstein Yoseph
director, 10 percent owner:
- 25000
1.1752 USD
7 years ago
Sep 12, 2017
Sell 22.4 K USD
Bornstein Yoseph
director, 10 percent owner:
- 20000
1.12 USD
7 years ago
Sep 06, 2017
Sell 25 K USD
Bornstein Yoseph
director, 10 percent owner:
- 25000
1 USD
7 years ago
Sep 06, 2017
Sell 659 USD
Bornstein Yoseph
director, 10 percent owner:
- 610
1.08 USD
7 years ago
Sep 06, 2017
Sell 20.2 K USD
Bornstein Yoseph
director, 10 percent owner:
- 20000
1.01 USD
7 years ago
Aug 30, 2017
Sell 5.35 K USD
Bornstein Yoseph
director, 10 percent owner:
- 5000
1.07 USD
7 years ago
Aug 30, 2017
Sell 5.3 K USD
Bornstein Yoseph
director, 10 percent owner:
- 5000
1.0605 USD
7 years ago
Aug 24, 2017
Sell 10.3 K USD
Bornstein Yoseph
director, 10 percent owner:
- 10000
1.0311 USD
7 years ago
Aug 25, 2017
Sell 16.2 K USD
Bornstein Yoseph
director, 10 percent owner:
- 15000
1.0808 USD
7 years ago
Jun 16, 2017
Sell 119 K USD
Lewkowicz Leon
10 percent owner
- 71224
1.67 USD
8 years ago
Mar 14, 2016
Bought 49.8 K USD
SCHIFFMAN GREGORY T
Chief Financial Officer
+ 166000
0.3 USD
8 years ago
Mar 14, 2016
Bought 52.3 K USD
SCHIFFMAN GREGORY T
Chief Financial Officer
+ 124500
0.42 USD
8 years ago
Mar 14, 2016
Bought 24.9 K USD
SCHIFFMAN GREGORY T
Chief Financial Officer
+ 83000
0.3 USD
8 years ago
Dec 29, 2015
Sell 47.2 K USD
Stratton Kenneth Blair
General Counsel
- 104549
0.4512 USD
13 years ago
May 20, 2011
Sell 33.4 K USD
TSUKAMOTO ANN
EVP, Research and Development
- 49100
0.68 USD
14 years ago
May 18, 2010
Sell 9.33 K USD
KOSHY GEORGE
- 8801
1.06 USD
14 years ago
Mar 16, 2010
Sell 19.2 K USD
KOSHY GEORGE
- 15850
1.21 USD
14 years ago
Mar 17, 2010
Sell 36.9 K USD
Young Rodney KB
CFO
- 30000
1.23 USD
14 years ago
Mar 16, 2010
Sell 35.9 K USD
Stratton Kenneth Blair
General Counsel
- 29683
1.21 USD
15 years ago
Nov 20, 2009
Sell 3.98 K USD
Young Rodney KB
CFO
- 3647
1.09 USD
15 years ago
May 12, 2009
Sell 17 K USD
KOSHY GEORGE
- 10000
1.7 USD
15 years ago
Apr 16, 2009
Sell 73.6 K USD
WEISSMAN IRVING
Director
- 43304
1.7 USD
15 years ago
Apr 16, 2009
Sell 11.4 K USD
WEISSMAN IRVING
Director
- 6696
1.7001 USD
15 years ago
Apr 02, 2009
Sell 28.7 K USD
KOSHY GEORGE
- 16602
1.73 USD
15 years ago
Apr 07, 2009
Sell 16.1 K USD
KOSHY GEORGE
- 10000
1.61 USD
15 years ago
Apr 03, 2009
Sell 28.1 K USD
Stratton Kenneth Blair
General Counsel
- 17018
1.6541 USD
15 years ago
Apr 03, 2009
Sell 241 K USD
MCGLYNN MARTIN M
President & CEO
- 145344
1.6614 USD
15 years ago
Apr 02, 2009
Sell 148 K USD
SCHWARTZ JOHN J
Director
- 88164
1.6749 USD
15 years ago
Apr 02, 2009
Sell 63.3 K USD
TSUKAMOTO ANN
EVP, Research and Development
- 36816
1.719 USD
15 years ago
Apr 02, 2009
Sell 58 K USD
Young Rodney KB
CFO
- 33800
1.7167 USD
15 years ago
Apr 02, 2009
Sell 22.3 K USD
Young Rodney KB
CFO
- 13292
1.68 USD
15 years ago
Apr 02, 2009
Sell 28.7 K USD
KOSHY GEORGE
- 16602
1.73 USD
15 years ago
Apr 02, 2009
Sell 258 K USD
WEISSMAN IRVING
Director
- 150000
1.7188 USD
16 years ago
Jun 27, 2008
Sell 2.52 K USD
WEISSMAN IRVING
Director
- 2100
1.2 USD
16 years ago
Jun 27, 2008
Sell 4.96 K USD
WEISSMAN IRVING
Director
- 4100
1.21 USD
16 years ago
Jun 27, 2008
Sell 6.95 K USD
WEISSMAN IRVING
Director
- 5700
1.22 USD
16 years ago
Jun 27, 2008
Sell 615 USD
WEISSMAN IRVING
Director
- 500
1.23 USD
16 years ago
Jun 27, 2008
Sell 4.84 K USD
WEISSMAN IRVING
Director
- 3900
1.24 USD
16 years ago
Jun 27, 2008
Sell 4 K USD
WEISSMAN IRVING
Director
- 3200
1.25 USD
16 years ago
Jun 27, 2008
Sell 628 USD
WEISSMAN IRVING
Director
- 500
1.255 USD
16 years ago
Jun 30, 2008
Sell 8.19 K USD
WEISSMAN IRVING
Director
- 7000
1.17 USD
16 years ago
Jun 30, 2008
Sell 4 K USD
WEISSMAN IRVING
Director
- 3387
1.18 USD
16 years ago
Jun 30, 2008
Sell 2.14 K USD
WEISSMAN IRVING
Director
- 1800
1.19 USD
16 years ago
Jun 30, 2008
Sell 57.4 K USD
WEISSMAN IRVING
Director
- 47813
1.2 USD
16 years ago
Apr 18, 2008
Sell 4.5 K USD
WEISSMAN IRVING
Director
- 3307
1.36 USD
16 years ago
Apr 18, 2008
Sell 22.3 K USD
WEISSMAN IRVING
Director
- 16293
1.37 USD
16 years ago
Apr 18, 2008
Sell 412 USD
WEISSMAN IRVING
Director
- 300
1.375 USD
16 years ago
Apr 18, 2008
Sell 35.3 K USD
WEISSMAN IRVING
Director
- 25554
1.38 USD
16 years ago
Apr 18, 2008
Sell 10.2 K USD
WEISSMAN IRVING
Director
- 7346
1.39 USD
16 years ago
Apr 18, 2008
Sell 15.7 K USD
WEISSMAN IRVING
Director
- 11230
1.4 USD
16 years ago
Apr 18, 2008
Sell 12.9 K USD
WEISSMAN IRVING
Director
- 9170
1.41 USD
16 years ago
Apr 18, 2008
Sell 9.66 K USD
WEISSMAN IRVING
Director
- 6800
1.42 USD
16 years ago
Jun 17, 2008
Sell 2.88 K USD
SCHWARTZ JOHN J
Director
- 2100
1.37 USD
16 years ago
Jun 16, 2008
Sell 12.6 K USD
SCHWARTZ JOHN J
Director
- 9200
1.37 USD
16 years ago
Jun 16, 2008
Sell 19.2 K USD
SCHWARTZ JOHN J
Director
- 13900
1.38 USD
16 years ago
Jun 17, 2008
Sell 30.8 K USD
SCHWARTZ JOHN J
Director
- 22500
1.3701 USD
16 years ago
Apr 18, 2008
Sell 4.5 K USD
WEISSMAN IRVING
Director
- 3307
1.36 USD
16 years ago
Apr 18, 2008
Sell 22.3 K USD
WEISSMAN IRVING
Director
- 16293
1.37 USD
16 years ago
Apr 18, 2008
Sell 412 USD
WEISSMAN IRVING
Director
- 300
1.375 USD
16 years ago
Apr 18, 2008
Sell 35.3 K USD
WEISSMAN IRVING
Director
- 25554
1.38 USD
16 years ago
Apr 28, 2008
Sell 10.2 K USD
WEISSMAN IRVING
Director
- 7346
1.39 USD
16 years ago
Apr 18, 2008
Sell 15.7 K USD
WEISSMAN IRVING
Director
- 11230
1.4 USD
16 years ago
Apr 18, 2008
Sell 12.9 K USD
WEISSMAN IRVING
Director
- 9170
1.41 USD
16 years ago
Apr 18, 2008
Sell 9.66 K USD
WEISSMAN IRVING
Director
- 6800
1.42 USD
16 years ago
Dec 20, 2007
Sell 39.3 K USD
WEISSMAN IRVING
Director
- 24900
1.58 USD
16 years ago
Dec 20, 2007
Sell 159 USD
WEISSMAN IRVING
Director
- 100
1.59 USD
16 years ago
Dec 21, 2007
Sell 58.5 K USD
WEISSMAN IRVING
Director
- 39001
1.5 USD
16 years ago
Dec 21, 2007
Sell 4.53 K USD
WEISSMAN IRVING
Director
- 2999
1.51 USD
16 years ago
Dec 21, 2007
Sell 1.52 K USD
WEISSMAN IRVING
Director
- 1000
1.52 USD
16 years ago
Dec 21, 2007
Sell 4.58 K USD
WEISSMAN IRVING
Director
- 2992
1.53 USD
16 years ago
Dec 21, 2007
Sell 6.17 K USD
WEISSMAN IRVING
Director
- 4008
1.54 USD
16 years ago
Dec 21, 2007
Sell 8.74 K USD
WEISSMAN IRVING
Director
- 5600
1.56 USD
16 years ago
Dec 21, 2007
Sell 12.4 K USD
WEISSMAN IRVING
Director
- 7882
1.57 USD
16 years ago
Dec 21, 2007
Sell 18.2 K USD
WEISSMAN IRVING
Director
- 11518
1.58 USD
17 years ago
Mar 07, 2007
Bought 23.5 K USD
OCONNELL DESMOND H JR
Director
+ 9000
2.6087 USD
17 years ago
Mar 06, 2007
Bought 2.43 K USD
OCONNELL DESMOND H JR
Director
+ 1000
2.428 USD
20 years ago
Jan 14, 2004
Sell 108 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 50000
2.15 USD
20 years ago
Jan 14, 2004
Sell 119 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 55900
2.13 USD
20 years ago
Jan 15, 2004
Sell 73.1 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 34000
2.15 USD
20 years ago
Jan 09, 2004
Sell 143 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 66000
2.17 USD
20 years ago
Jan 09, 2004
Sell 96.8 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 44000
2.2 USD
20 years ago
Jan 12, 2004
Sell 127 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 61000
2.09 USD
20 years ago
Jan 13, 2004
Sell 64.5 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 31000
2.08 USD
20 years ago
Jan 07, 2004
Sell 193 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 88636
2.18 USD
20 years ago
Jan 07, 2004
Sell 72.6 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 32845
2.21 USD
20 years ago
Jan 07, 2004
Sell 50.4 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 23000
2.19 USD
20 years ago
Jan 08, 2004
Sell 132 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 61000
2.17 USD
20 years ago
Jan 08, 2004
Sell 84 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 38164
2.2 USD
20 years ago
Jan 08, 2004
Sell 59.1 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 26750
2.21 USD
20 years ago
Jan 05, 2004
Sell 65.4 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 30000
2.18 USD
20 years ago
Jan 05, 2004
Sell 257 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 117200
2.19 USD
20 years ago
Jan 05, 2004
Sell 218 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 98650
2.21 USD
20 years ago
Jan 06, 2004
Sell 212 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 96240
2.2 USD
20 years ago
Jan 06, 2004
Sell 122 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 56000
2.18 USD
20 years ago
Dec 31, 2003
Sell 75.6 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 27000
2.8 USD
20 years ago
Jan 02, 2004
Sell 54.5 K USD
MILLENNIUM MANAGEMENT LLC
10 percent owner
- 27000
2.02 USD
7. News
Microbot Medical Stock Rises After Completing ACCESS-PVI Trial MBOT announces the successful completion of its ACCESS-PVI clinical trial for the LIBERTY Endovascular Robotic Surgical System, paving the way for FDA submission. zacks.com - 1 month ago
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 U.S. Food and Drug Administration (FDA) Submission Expected by end of 2024 Clinical Data to be Presented at Medical Conference in Early 2025 BRAINTREE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced that it has successfully completed enrollment and follow up for all patients in its ACCESS-PVI human clinical trial. globenewswire.com - 1 month ago
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up Confirms the Company on Track for FDA 510(k) Submission by end of 2024 Completes All IDE required Tests and Receives Final IDE Approval from the FDA for the ACCESS-PVI Study BRAINTREE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced that it is currently experiencing an acceleration of patient enrollment for ACCESS-PVI human clinical trial for LIBERTY®. globenewswire.com - 1 month ago
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024 Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024 globenewswire.com - 2 months ago
Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY Microbot Medical (MBOT) signs a Phase 2 collaboration agreement with Corewell Health to advance remote telesurgery for endovascular procedures using LIBERTY. zacks.com - 2 months ago
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System The agreement follows the successful completion of Phase 1 which evaluated the viability of LIBERTY as a remote telesurgery platform globenewswire.com - 2 months ago
Microbot Medical (MBOT) Gets Quality Certification for its System Microbot Medical (MBOT) secures ISO 13485:2016 certification for its LIBERTY Endovascular Robotic System, a milestone that streamlines European and FDA regulatory compliance for future commercialization. zacks.com - 2 months ago
Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization The ISO 13485 certification is a validation of the Company's robust quality system The ISO 13485 certification is a validation of the Company's robust quality system globenewswire.com - 3 months ago
Microbot Medical (MBOT) Inks Deal to Test Autonomous Robotics Microbot Medical (MBOT) announces an agreement with Emory University to explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system. zacks.com - 3 months ago
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System The evaluation phase will explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system The evaluation phase will explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system globenewswire.com - 3 months ago
Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center As the third and final clinical site, Memorial Sloan Kettering Cancer Center joins Brigham Women's Hospital and Baptist Hospital of Miami as sites for the pivotal human clinical trial As the third and final clinical site, Memorial Sloan Kettering Cancer Center joins Brigham Women's Hospital and Baptist Hospital of Miami as sites for the pivotal human clinical trial globenewswire.com - 4 months ago
Microbot Medical (MBOT) Progresses in Its Human Clinical Trial Microbot Medical's (MBOT) latest patient enrollment in its pivotal human clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY system. zacks.com - 4 months ago
8. Profile Summary

Microbot Medical Inc. MBOT

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 15.7 M
Dividend Yield 0.00%
Description Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Contact 25 Recreation Park Drive, Hingham, MA, 02043 https://www.microbotmedical.com
IPO Date March 25, 1992
Employees 21
Officers Ms. Rachel Vaknin Chief Financial Officer Dr. Simon Sharon MBA, MSc Chief Technology Officer & GM of Microbot Israel Mr. Harel Gadot Co-Founder, President, Chief Executive Officer & Chairman Dr. Juan Diaz-Cartelle Chief Medical Officer Mr. Yoseph Bornstein Co-Founder & Independent Director